HUTCHMED (China) Limited
HCM
$14.16
-$0.14-0.98%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 0.00% | -99.57% | 0.00% | 3,714.17% | 0.00% |
| Total Depreciation and Amortization | 0.00% | 17.52% | 0.00% | 0.48% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00% | 101.48% | 0.00% | -1,514.38% | 0.00% |
| Change in Net Operating Assets | 0.00% | 84.78% | 0.00% | -351.24% | 0.00% |
| Cash from Operations | 0.00% | 111.30% | 0.00% | -280.75% | 0.00% |
| Capital Expenditure | 0.00% | 47.33% | 0.00% | -18.43% | 0.00% |
| Sale of Property, Plant, and Equipment | 0.00% | 266.67% | 0.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00% | -256.94% | 0.00% | 132.43% | 0.00% |
| Cash from Investing | 0.00% | -367.17% | 0.00% | 119.41% | 0.00% |
| Total Debt Issued | 0.00% | 175.84% | 0.00% | -70.36% | 0.00% |
| Total Debt Repaid | 0.00% | -- | -- | -- | 0.00% |
| Issuance of Common Stock | 0.00% | -56.55% | 0.00% | 95.73% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00% | -115.93% | 0.00% | 391.87% | 0.00% |
| Foreign Exchange rate Adjustments | 0.00% | -68.55% | 0.00% | 271.96% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00% | 8.90% | 0.00% | 13.51% | 0.00% |